Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes

NCT02081599 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Teneli (Teneligliptin)
DRUG: Placebo
DRUG: Insulin

Sponsor

Tanabe Pharma Corporation